CSI Market
Sign In | Register

Tiziana Life Sciences Ltd (TLSA) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access TLSA Annual Cash Flow →
The table below presents a historical view of Tiziana Life Sciences Ltd's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income-18.43
Depreciation & amortization0.01
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss-0.15
Financial Instruments and Foreign Currency Transaction0.00
Bonus To Be Settled In Equity-
Net Increase In Related Party Receivables-
Net Increase In Related Party Payables-
Adjustments For Decrease Increase In Other Operating Receivables-
Adjustments For Increase Decrease In Other Liabilities-
Depreciation Of Rightofuse Asset-
Profits Losses On Disposal Of Investments And Changes In Value Of Investments-
Income Taxes Paid Refund Classified As Operating Activities-
Impairment Charges-
Adjustments For Sharebased Payments-
Adjustments For Sharebased Payments Warrants-
Options Forfeited During The Year-
F V Loss On Investment-
Adjustments For Gains Losses On Disposal Of Financial Assets-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.63
Discontinued operations0.00
Net Cash flow from Operating Activities-12.85
Investing Activities
Capital Expenditures-0.02
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchase Of Act D-
Proceeds From Finance Lease-
Investment In Related Party-
Purchase Of Treasury Amount-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Sale and Collection of Finance Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net3.06
Discontinued operations0.00
Net Cash Flow from Investing Activities3.04
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net10.01
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities10.01
Effect of exchange rate on cash flow0.20
Discontinued operations0.00
Free Cash Flow-12.87
Total Cash Flow3.72
4 historic quarters locked

Sign in to unlock the full Tiziana Life Sciences Ltd cash flow history.

Sign In Create Free Account

About Tiziana Life Sciences Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-051015

Figures are derived from filed reports and may be restated. Historical data is subject to revision.